News and Insights of 3D Printing and Manufacturing
Humabiologics, an industry leader in providing human-derived biomaterials for regenerative medicine, founded by scientists and tissue industry experts to address the gap between the gift of donated human tissues and researchers, and Fisher Scientific, a global leader in life sciences, are partnering to serve researchers in academia and industry who are working on regenerative medicine research.
The 2021 3D Printing Industry Awards shortlists are open for voting, have your say now.
Philadelphia-headquartered 3D bioprinting company Allevi has launched the Skin Bioink Kit. A material package, this kit is to be used in conjunction with its 3D bioprinters to produce patches of skin. It aims to allow tissue engineers to design multi-layered skin patches that are more akin to natural human skin.
Swedish 3D bioprinter and materials developer CELLINK has announced the launch of BIO X6, a new six-printhead bioprinting system that allows the combination of multiple materials, cells and tools. It also features an intelligent exchangeable printhead system and CELLINK’s patented Clean Chamber Technology to enhance advanced research and clinical applications.
Leading 3D printer OEM 3D Systems and Israeli bioprinting material developer CollPlant have announced a joint development agreement seeking to create tissue and scaffold bioprinting solutions for third party collaborators.
A worldwide collective of researchers and scientists from universities, institutions, and hospitals have come together to produce a roadmap for 3D bioprinting.
A payload containing 3D printed supplies for the 3D BioFabrication Facility (BFF) has arrived on board the International Space Station (ISS) docked 248 miles above the Earth’s surface. The cargo contained samples of human cells, bio-inks, and a set of new 3D printed ceramic fluid manifolds to replace the previously used printed polymers.
UPM, a Finnish alternative energy and material company, has launched a range of bioinks known as GrowInk, designed for various 3D bioprinting applications such as tissue engineering and regenerative medicine.
Biomedical engineers from Rutgers University in New Jersey have developed a bio-ink for 3D printing that enables the construction of scaffolds to support growing human tissues. Significantly, the stiffness of the scaffolds can be controlled depending on the mixture of ink used, enabling applications for different types of tissues for repair or replacement.
Researchers from the New York-based Clarkson University have developed a custom bioink and deployed it to create a range of skin-compatible 3D printed biosensors.